Objectives. To assess perspectives of patients with voice problems and identify factors associated with the likelihood of referral to voice therapy via the CHEER (Creating Healthcare Excellence through Education and Research) practice-based research network infrastructure.
V oice disorders are associated with negative quality-oflife impact, substantial indirect costs from voicerelated work absenteeism and short-term disability claims, and direct health care cost estimates approaching $5 billion annually. [1] [2] [3] Treatment for dysphonia may involve medical, surgical, and/or behavioral (voice) therapy. Voice therapy may be offered as the primary modality, an adjunct to medical or surgical treatment, or a means to aid in diagnosis. 4 Voice therapy has been shown to be effective in patients with muscle tension dysphonia, 5, 6 phonotraumatic benign vocal fold lesions, 7-10 age-related vocal fold atrophy, 11 neurologic disorders (including Parkinson's disease), 12, 13 and reflux-related 14 voice disorders. To date, most studies of voice therapy have been conducted in academic tertiary voice clinics, while other investigations regarding the utilization of voice therapy employed surveys of otolaryngologists, which may be subject to recall bias. [15] [16] [17] [18] [19] As voice disorders are commonly seen in a variety of settings, 20 broadening our knowledge regarding the diagnosis of voice disorders and voice therapy referral patterns/utilization is necessary. Creating Healthcare Excellence through Education and Research (CHEER), 21 a practice-based research network focused on hearing and communication disorders, is based on a collaborative model of academic and community partnerships in otolaryngology and had an initial focus on hearing and balance with previously reported data on patients with tinnitus and/or dizziness. 21 The CHEER network is an ideal platform for investigating practice and treatment patterns of various otolaryngologic disorders across multiple centers in the United States. Utilizing a practice-based research network to collect the data engages a broad range of interdisciplinary care sites and settings and accesses a diverse population of patients, ensuring that the information collected supports expedient translation. We hypothesized that the functionality of the CHEER network could be successfully utilized to study questions related to voice disorders. We aimed to characterize the patient population by assessing sociodemographics and vocal symptom levels as well as self-reported voice-related diagnoses and treatment recommendations. We also sought to understand what factors predicted the likelihood of referral for voice therapy.
Methods

Data Source and Sample
A brief survey of CHEER sites was conducted in March 2012. The survey identified the number of otolaryngologists and speech-language pathologists who treat voice problems in their practice, and it provided estimates of monthly visits and referrals for patients with voice problems. Sites reporting interest and adequate relevant patient volumes were invited to participate. Of the 24 active CHEER network sites, 10 participated in the current study. Fourteen sites, 7 academic and 7 private practice, responded to the initial survey, with 11 agreeing to participate; 1 did not enroll patients.
New patients with a voice complaint were invited to complete a brief survey that included demographic data, voice diagnoses, severity of voice problems, treatment recommendations, and outcomes. All data were self-reported by patients at the end of their clinic visits, including sociodemographic factors, diagnoses, and receipt of voice therapy recommendation. We did not have access to providers' diagnoses or ICD-9 codes. All participants were 18 years old. Sites were categorized as academic versus nonacademic based on affiliation with a teaching medical school; completion of laryngology fellowship and availability of speechlanguage pathologists within the practice were assessed through publicly available information listed on practice websites, with additional inquiries via phone as needed. A total of 249 patients were identified for analysis after exclusion of patients who were missing data on sex, age, and voice therapy recommendations (n = 40).
Measures
To collect patient-reported data on diagnoses and treatment recommendations, multiple-choice questions were utilized. Participants were asked, ''What is your diagnosis? Please mark all that apply.'' Multiple options were provided as possible responses, as well as the option of specifying ''other'' or ''not sure.'' We used affirmative responses to the question ''Was voice therapy recommended for you at today's visit?'' to identify patients who received a voice therapy recommendation. In addition, the Voice Handicap Index-10, a wellestablished scale reflecting patient opinions about how the voice has affected quality of life, was collected. 22 To protect patient privacy, surveys were assigned unique identifiers. The Duke University Institutional Review Board (IRB) approved the study and extended to CHEER community sites. IRB approvals were also obtained from CHEER sites that required independent IRB approval. Project enrollment began on November 27, 2012, and continued through December 5, 2013, when the recruitment goal was met. Analysis of deidentified data was deemed exempt by the IRB of the University of Minnesota.
Study data were collected and managed through Research Electronic Data Capture (REDCap) tools hosted at Duke University. 23 REDCap is a secure, web-based application designed to support data capture for research studies. Data were extracted from the REDCap database and analyzed via SAS 9.3 (Statistical Analysis Software Institute, Cary, North Carolina).
Analytic Methods
Bivariate comparisons were used to evaluate socioeconomic factors and the distributions of reported voice-related diagnoses and treatment recommendations. The factors associated with a voice therapy recommendation were then assessed, controlling for age, sex, race, and educational attainment, via a multivariate regression model. Because units (individual patients) were clustered within CHEER sites and a single participant could have multiple diagnoses, generalized estimating equations models with clustered standard errors were used. To optimize model fit, only diagnoses in the upper 2 quartiles (ie, the most common) were employed as covariates, although all patients were included in the analysis regardless of diagnosis. 24 The generalized estimating equation regression models controlled for individual demographic and clinical covariates, including age, sex, race, education, selfreported diagnosis, and site status (academic and nonacademic). Because income and education were closely collinear and self-reported income is frequently inaccurate, income was excluded from our model. We also excluded tobacco use a priori in the model due to its potentially differential effects on a subset of the diagnoses. Sensitivity analysis confirmed that model fit was superior when tobacco use was excluded. The primary goal in this context was to examine factors associated with patient-reported voice therapy recommendation.
Results
Description of the Practice-Based Research Network
Of the 24 active CHEER network sites, 10 participated in the current study. Participating sites were located in Massachusetts, New York, North Carolina, Oregon, Pennsylvania, Texas, and Virginia. Of the 10 sites, 6 had at least 1 fellowship-trained laryngologist, and 3 others had general otolaryngologists with a practice interest in laryngology. This constituted 30 otolaryngology physicians. Eighty percent of practices had 1 speechlanguage pathologists practicing out of the same office; 50% of practices were affiliated with an academic teaching hospital; and the other 50% were in private practice settings. The 5 academic sites enrolled a total of 145 patients (58%), and the 5 private sites enrolled a total of 104 patients (42%).
Description of the Population
Of all participants, 68% were women, and 82% were white. More than half the participants were .50 years old (66%), earned .$40,000 (62%), and had a bachelor degree or higher (52%). Patient sociodemographics are shown in Table 1 .
Voice Problem Characteristics and Severity
When asked to describe the frequency and severity of their voice problem, 89% of patients reported that it persisted for .4 weeks ( Table 2) . However, only 22% reported having to miss 1 days of work in the last year; 56% of patients reported having a continual voice problem as opposed to an ''off and on'' problem. The Voice Handicap Index-10 score varied, but most patients (79%) had a score ranging from 10 to 29 (mean 6 SD, 17.9 6 8.0).
Patient-Reported Diagnoses
Just over half the patients self-reported receiving a single diagnosis (54%). Among these, vocal strain/excessive tension (26%), reflux (13%), and vocal fold paralysis (12%) were reported the most frequently ( Figure 1) . Seventeen percent of patients reported being ''not sure'' about their diagnosis. The majority of patients with vocal strain/excessive tension and vocal fold paralysis were seen in an academic setting (71% and 79%, respectively).
Forty-six percent of patients reported multiple diagnoses. Among patients reporting multiple diagnoses, reflux (28%), vocal strain/excessive tension (27%), and allergy (16%) were the most frequently reported (Figure 2 ).
Patient-Reported Treatment Recommendations
Among patients who reported receiving a single treatment recommendation, referral for speech therapy or voice therapy was most frequent (34%; Figure 3 ). Other common treatment types for patients reporting a single treatment recommendation included antireflux medication (17%), surgery (8%), and speech pathology referral for stroboscopy (8%).
Fifty-nine percent of patients reported receiving multiple treatment recommendations. Among those, the most frequently mentioned treatments were antireflux medication (59%), referral to speech pathology for speech therapy or voice therapy (50%), and voice lessons (21%; Figure 4 ).
Overall, 67% of patients received a recommendation for speech/voice therapy and 40% for reflux management.
Recommendation for Voice Therapy
The diagnostic categories from which the greatest proportions of patients reported a speech/voice therapy recommendation were (1) vocal strain/excessive tension (92 of 107, 86%), (2) neurologic problem (voice and/or other; 6 of 7, 86%), and (3) irritable larynx syndrome (22 of 26, 85%; Table 3 ). After multivariable regression including adjustment for other covariates, the factors most strongly associated with a voice therapy recommendation were (1) diagnoses including vocal strain/excessive tension and vocal fold paralysis and (2) academic site ( Table 4 ).
Discussion
This study demonstrates that the CHEER infrastructure is a valuable resource for investigating dysphonia. This CHEER cohort comprised a sizable group of adults with dysphonia from a broad geographic distribution, and the racial distribution was similar to that described in the overall CHEER cohort. 25 Income and educational information were not available on the overall CHEER cohort, but the enrolled group was similar to voice patient populations that have been described in the past, with a female preponderance (in contrast to the overall CHEER cohort) and a majority reporting white race. [25] [26] [27] [28] The degree of voice-related handicap reported by the group was generally consistent with what might be expected, with the majority reporting a Voice Handicap Index-10 above the cutoff for ''abnormal.'' 29 In contrast to prior findings, 27 a relative minority reported missing work related to the voice problem. However, similar to prior reports, 27 most patients indicated having a recurrent or long-standing voice problem, thereby raising the possibility of voice-related presenteeism, 30 which was not assessed.
Diagnoses
About half of patients reported a single diagnostic category, and of those, ''not sure'' was most common. Although this represented only 7% of the overall enrolled population, it was nevertheless an unexpected finding and may point to an opportunity to improve patient-provider communication. It is possible that some patients did not understand what was explained to them. Alternatively, otolaryngologists have been reported to be less comfortable diagnosing voice disorders without obvious structural abnormalities; thus, it is possible that workup and/or diagnostic decision making was still in progress. 31 Finally, it is possible that the patient had received a prior diagnosis that was not the same as the newly given diagnosis, which frequently occurs following specialty evaluation of a voice problem, 32,33 thereby potentially resulting in some uncertainty. Although this level of detail was not available for analysis in the current data set, patient comprehension and communication with the otolaryngologist, as well as subsequent patient outcomes, are important areas for future research. Reflux, allergy, muscle tension dysphonia, and benign vocal fold lesions were commonly reported diagnoses. Reflux is a prominent comorbid diagnosis in this group of patients with voice complaints and reflects the prevalent perception among otolaryngologists that reflux plays an important role in voice disorders. 34, 35 The link between allergy and dysphonia is poorly understood, with some authors reporting a high prevalence of allergies among patients with dysphonia 36, 37 and others indicating that the allergy diagnosis may be revised upon specialty or subspecialty assessment of dysphonia. 38 The prevalence of muscle tension dysphonia and benign vocal fold lesions in this study was similar to that in other populations presenting with dysphonia. 39, 40 Treatments There were some minor differences in the distribution of treatment recommendations between those receiving 1 and .1 recommendations, but in both groups, speech therapy and reflux medications were most common. For nearly all diagnostic groups (except ''inflammatory/infections'' and ''other''), the majority reported a recommendation for voice therapy. With 60% of practices having a laryngologist with fellowship training, 30% having otolaryngologists interested in voice, and 80% having a speech-language pathologist in the same practice, the frequency of voice therapy utilization in CHEER is likely greater than that of other practice settings without the same degree of voice-related interest and/ or expertise. A study based on data from the National Ambulatory Medical Care Survey found a 12.5% referral rate among otolaryngologists for speech-language pathology evaluation/treatment, 41 while one based on a national claims database identified a referral rate of only 5% among otolaryngologists 42 ; variable rates of referral may reflect practicelevel differences in voice-related expertise or preferences. Multivariable regression adjusting for potentially confounding variables indicated that vocal strain/excessive tension was associated with a 5.7-fold increased likelihood of referral, consistent with the wide acceptance of voice therapy as the primary mode of treatment. We also found that vocal fold paralysis was associated with a 1.8-fold increased Figure 3 . Percentage of self-reported treatment recommendations of patients reporting only 1 treatment in CHEER. Note that diet/lifestyle modifications for reflux, steroid inhaler to use by mouth, reflux test, consult with gastroenterologist, consult with pulmonologist, consult with allergist, voice amplification antibiotic, allergy, imaging (eg, computed tomography, magnetic resonance imaging), consult with neurologist, voice rest, and Botox/botulinum toxin injection treatment recommendations together accounted for 7% of patient selfreported treatment recommendations and are excluded from this figure. SLP, speech-language pathologist. Figure 2 . Diagnoses of CHEER patients self-reporting multiple diagnoses (2) . Percentage sum is .100, as patients were able to choose multiple diagnoses. VF, vocal fold.
likelihood of referral (P \ .0001). This finding is of interest because the role of voice therapy in the management of vocal fold paralysis has not been clearly defined. [43] [44] [45] Our data do not differentiate among voice therapy referral for indirect voice therapy only, voice therapy as an adjunct to concurrent or planned surgical treatment, or voice therapy as the primary treatment modality. Given our finding that the diagnosis of vocal fold paralysis increases the likelihood of voice therapy referral, future studies are warranted examining the use of voice therapy in the management of vocal fold paralysis. Diagnoses of benign vocal fold lesions/granuloma were not associated with an increased likelihood of voice therapy referral (P = .06). This was somewhat surprising, since it is commonly accepted that voice therapy is often the first-line treatment for certain phonotraumatic lesions as well as for vocal process granulomas, 46 but this may also reflect individual practice differences or other unmeasured factors.
Academic practice setting was strongly associated with increased likelihood of reported referral to speech/voice therapy (odds ratio, 5.62; P \ .0001), even though the analysis was adjusted for all other factors, including diagnoses. This may be a reflection of the likelihood of having fellowship-trained laryngologists, as the 2 variables were nearly completely linked, rather than a result of having or not having speech pathologists on site. Alternatively, it could reflect underlying differences in diagnosis mix, referral patterns, or reimbursement or other structural differences that influence practice patterns. For example, it was recently observed that coassessment with a speech pathologist and laryngologist is associated with higher likelihood of recommendation for and utilization of speech therapy services. 47 Thus, even among practice sites with voice interest/expertise, there was varied use of voice therapy. This variability in treatment may have implications for patient outcomes. Figure 4 . Percentage of self-reported treatment recommendations of patients reporting multiple treatment recommendations in CHEER. SLP, speech-language pathologist. Consult with allergist, steroid inhaler to use by mouth, consult with pulmonologist, Botox/botulinum toxin injection, reflux test, consult with gastroenterologist, and antibiotic and steroid treatment together accounted for \5% of treatments and are excluded from this figure. Percentage sum is .100, as patients were able to choose multiple diagnoses.
Limitations
Although these data demonstrate the feasibility and value of collecting data through a practice-based network to learn about the experiences of patients with dysphonia, a number of limitations need to be acknowledged. First, the diagnostic and treatment data presented here are by selfreport, which was the intended study design. Future work will include the examination of similarities and differences between patient and provider report of diagnostic and treatment data. Second, as this was a cross-sectional study, we did not collect longitudinal follow-up, ask follow-up questions, or obtain medical records for further information. Third, patient report of treatment recommendations such as speech therapy does not necessarily translate directly to speech therapy attendance or adherence, 48 particularly among those with severe voice-related quality-of-life changes, 49 but the CHEER network may be a useful framework within which to investigate longitudinal questions in the future.
Conclusions
The CHEER practice-based research network successfully enrolled a representative cohort of patients with dysphonia. Most reported long-standing or recurrent dysphonia. The most commonly reported diagnoses were reflux and vocal strain, and most commonly reported treatment recommendations were antireflux medications and speech/voice therapy. Academic practice site was predictive of the likelihood of referral to speech/voice therapy. The study identified a possible need for improved patient-provider communication regarding the nature of the voice disorder. Investigation of voice therapy adherence and predictors of adherence among a multicentered cohort of patients may identify areas for improved treatment outcomes.
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